Bipartisan Policy Center To Unveil FDA-Focused Medical Innovation Proposals By Summer

As the Bipartisan Policy Center (BPC) last week launched its own medical innovation initiative, medical product experts, including a former FDA commissioner, said Congress, the White House and FDA should look to increase the patient perspective in innovative research and realign the incentive structure to encourage industry to pursue treatments earlier in the disease cycle in areas like cancer. BPC is looking at the issue with a focus on FDA as the House, Senate and Obama administration each pursue efforts...